DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nulojix (Belatacept) - Current Clinical Trials

 
 



Nulojix Related Clinical Trials

Safety and Efficacy of a Steroid-free, Calcineurin Inhibitor-free, Belatacept-based Immunosuppressive Regimen [Active, not recruiting]

Optimization of NULOJIX� (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation [Recruiting]

Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers [Completed]

Belatacept 3 Month Post Transplant Conversion Study [Recruiting]

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based [Recruiting]

Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) [Recruiting]

Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients [Active, not recruiting]

Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant [Recruiting]

Belatacept Post Depletional Repopulation to Facilitate Tolerance [Active, not recruiting]

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression [Not yet recruiting]

Belatacept Early Steroid Withdrawal Trial [Recruiting]

Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients [Active, not recruiting]

Belatacept Conversion in Proteinuric Kidney Transplant Recipients [Not yet recruiting]

A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation [Completed]

Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function [Recruiting]

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores [Recruiting]

Phase II Pharmacokinetics, Efficacy, and Safety of Belatacept in Pediatric Renal Transplant Recipients [Recruiting]

Belatacept Pharmacokinetic Trial in Renal Transplantation [Completed]

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Terminated]

Regimen Optimization Study [Not yet recruiting]

Efficacy of Belatacept in Reducing DSA [Recruiting]

Belatacept in Liver Transplant Recipients [Terminated]

Pattern Of Use Of Belatacept In US Transplant Recipients [Active, not recruiting]

Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney [Completed]

Belatacept Therapy for the Failing Renal Allograft [Recruiting]

Belatacept in Kidney Transplantation of Moderately Sensitized Patients [Recruiting]

Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study [Active, not recruiting]

Optimization of NULOJIX® (Belatacept) Usage As A Means of Avoiding Calcineurin Inhibitor (CNI) and Steroids in Renal Transplantation [Suspended]

Safety Profile of Nulojix in Home Infusion Settings [Completed]

A Belatacept Compassionate Use Study for Patients With a Kidney Transplant [Approved for marketing]

A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [Completed]

Belatacept for Renal Transplant Recipients With Delayed Graft Function [Recruiting]

LEA29Y (Belatacept) Emory Edmonton Protocol [Completed]

Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study [Active, not recruiting]

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) [Completed]

Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant [Completed]

Subcutaneous Pharmacokinetics Study [Completed]

Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy [Recruiting]

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Completed]

Renal Allograft Tolerance Through Mixed Chimerism (Belatacept) [Not yet recruiting]

Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [Withdrawn]

Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) [Recruiting]

Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus [Active, not recruiting]

A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017